Real-world Effectiveness and Safety of Brentuximab Vedotin: A Retrospective Cohort Study from a Tertiary Care Hospital
{{output}}
Background: Brentuximab vedotin (BV) is widely used in CD30-positive lymphomas, but real-world outcomes may differ from clinical trials due to patient heterogeneity and prior treatment exposure. This study evaluated effectiveness... ...
